Impact of Breathing Exercises and Meditation on Improving Quality of Life in Glaucoma Patients
NCT05960513 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50
Last updated 2023-10-18
Summary
Glaucoma is a chronic disease that causes loss of vision and potentially blindness as a result of optic nerve damage, often due to increased intraocular pressure. Glaucoma is currently the leading cause of irreversible blindness worldwide.1 In 2020, 4.1 million and 3.6 million adults over the age of 50 suffered from mild to severe glaucoma-induced visual impairment and blindness, respectively.1 However, these figures are likely underestimated since glaucoma can remain asymptomatic until later stages in disease progression.2 The relaxation response evoked by mind-body interventions, such as breathing exercises and meditation, is known to reduce stress and improve quality of life (QOL). In a recent study, mindfulness-based meditation was found to reduce intraocular pressure and improve QOL in patients with glaucoma.3 A feasibility study will be conducted using a mixed-method design to assess the feasibility of the online delivery of an intervention titled Breathing Exercises followed by Meditation for potentially enhancing the QOL and mental health of glaucoma patients. Upon recruitment, participants will undergo blocked randomization to either the intervention arm or usual care arm, stratified by sex. Participants in each arm will complete online questionnaires at baseline and after 12 weeks to collect data on health-related quality of life (HRQOL), depression symptoms, anxiety, and sleep quality using REDCap, an electronic data capturing system provided by Lawson Health Research Institute (LHRI). Our study can help to assess the feasibility of conducting a pilot study on breathing exercises followed by meditation to assess its effects in a sample of patients with glaucoma.
Conditions
- Glaucoma
- Depression
- Anxiety
- Quality of Life
- Sleep Disorder
Interventions
- BEHAVIORAL
-
Breathing Exercises followed by Meditation
Breathing exercises and Meditation taught by Prasanna Wellness, a non-profit organization, helps dissolve stress and create a proper system in the mind. These breathing exercises include slow deep breaths and rapid breaths and are followed by meditation. Meditation is a guided meditation that helps to eliminate stress and establish an apposite system in the mind, therefore inducing physiological and mental relaxation whilst the eyes are shut. The proposed duration and frequency of the follow-up will be 60-minutes weekly for 11 weeks.
Sponsors & Collaborators
-
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 40 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-11-01
- Primary Completion
- 2024-11-01
- Completion
- 2024-11-01
Countries
- Canada
Study Locations
More Related Trials
-
Leveraging WeChat Social-Media and Messaging Platform to Increase Physical Activity in Chinese Glaucoma Patients
NCT03567226 ·Status: COMPLETED ·Phase: NA
-
Assessment of the Ability to Distinguish Odors in Glaucoma Patients
NCT00304824 ·Status: COMPLETED
-
Matching Glaucoma With Impaired Cognition
NCT03695224 ·Status: UNKNOWN
-
Clinical Study of LPI With Different Laser Wavelengths
NCT02901730 ·Status: UNKNOWN ·Phase: NA
-
Glaucoma, Visual Field Loss, and Their Association With Life Space in Older Adults
NCT04396002 ·Status: RECRUITING
-
Acupuncture for Elevated Intraocular Pressure
NCT00307918 ·Status: TERMINATED ·Phase: PHASE3
-
Treating Psychosocial Distress in Glaucoma
NCT06053307 ·Status: COMPLETED ·Phase: NA
-
The Canadian Glaucoma Study
NCT00262626 ·Status: TERMINATED ·Phase: NA
-
Effects of Melatonin Supplementation on Sleep Quality in Patients With Advanced Glaucoma
NCT06868745 ·Status: COMPLETED ·Phase: NA
-
Impact of Glaucoma and Visual Field Loss on Life Space
NCT03673644 ·Status: ACTIVE_NOT_RECRUITING
-
Does Glaucoma Cause Loss of Brain Function?
NCT01303939 ·Status: COMPLETED ·Phase: NA
-
Intraocular Pressure Fluctuation in Patients With Glaucoma and in Healthy Patients During Standard Yoga Positions
NCT01915680 ·Status: COMPLETED
-
The Effects of an Antioxidant Formulation on Ocular Blood Flow
NCT01930487 ·Status: COMPLETED ·Phase: NA
-
Quality of Life After Glaucoma Surgery: Evaluating the Patient Perspective Across Surgical Options
NCT07303257 ·Status: RECRUITING
-
Safety of Topical Insulin Drops for Open-angle Glaucoma
NCT04118920 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Clinical Evaluation of Acupuncture in Treating Glaucoma
NCT04157530 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Efficacy of Selecta Laser Trabeculoplasty in Patients Undergoing Filtering Surgery
NCT05900063 ·Status: COMPLETED
-
Metformin as a Neuroprotective Therapy for Glaucoma
NCT05426044 ·Status: RECRUITING ·Phase: PHASE2
-
Functional Brain Changes of Primary Open-angle Glaucoma Patients
NCT02570867 ·Status: UNKNOWN
-
Blood Flow Regulation in Glaucoma
NCT02292381 ·Status: COMPLETED
-
Cellular Proteome From Leukocytes of Glaucoma Patients in Comparison With Patients With Alzheimer's Disease
NCT00691340 ·Status: WITHDRAWN
-
Nicotinamide Levels in Serum, Aqueous Humor, and Tear Film in Glaucoma and Correlations With Mitochondrial Damage-Associated Molecular Patterns (mtDAMPs) and Senescence-Associated Secretory Phenotype (SASP)
NCT07006194 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
OCT Angiography in the Glaucoma Diagnosis
NCT04437446 ·Status: UNKNOWN ·Phase: NA
-
Modifiable Factors and Glaucoma - RCT
NCT02972749 ·Status: COMPLETED ·Phase: NA
-
Effect of Nitrous Oxide (N2O) on Intraocular Pressure in Healthy Volunteers
NCT00967694 ·Status: COMPLETED ·Phase: PHASE4